for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Peijia Medical Ltd

9996.HK

Latest Trade

12.80HKD

Change

-0.20(-1.54%)

Volume

590,000

Today's Range

12.50

 - 

13.00

52 Week Range

10.80

 - 

39.10

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
13.00
Open
12.98
Volume
590,000
3M AVG Volume
16.45
Today's High
13.00
Today's Low
12.50
52 Week High
39.10
52 Week Low
10.80
Shares Out (MIL)
671.33
Market Cap (MIL)
8,727.35
Forward P/E
-21.32
Dividend (Yield %)
--

Next Event

Peijia Medical Ltd Annual Shareholders Meeting

Latest Developments

More

Peijia Medical Enters Collaboration And License Agreement, Among Others

Peijia Medical Says Informed By Chairman Of Intention To Acquire Co's Shares From Open Market

Peijia Medical Says HY Revenue RMB51.7 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Peijia Medical Ltd

Peijia Medical Ltd is a China-based holding company mainly engaged in the research and development of interventional procedural medical devices. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The Company's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The Company operates its businesses primarily in domestic market.

Industry

Biotechnology & Drugs

Contact Info

No.8 Zhongtian Lane

Suzhou Industrial Park

SUZHOU, JNG

China

https://www.peijiamedical.com/

Executive Leadership

Yi Zhang

Executive Chairman of the Board, Chief Executive Officer, Chief Technology Officer

Leo Tsai

Chief Financial Officer

Kongrong Karl Pan

Chief Operating Officer

Xiaoli Shi

Vice President - Clinical and Regulatory Affairs

Jian Fong Tan

Vice President - Advanced Technology

Key Stats

2.00 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2020

0.0K

2021(E)

0.2K
EPS (CNY)

2020

-4.430

2021(E)

-0.505
Price To Earnings (TTM)
--
Price To Sales (TTM)
93.44
Price To Book (MRQ)
2.05
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.19
LT Debt To Equity (MRQ)
0.10
Return on Investment (TTM)
-13.76
Return on Equity (TTM)
-13.58

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up